🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 17 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/12/2019 | 92,49 | 93,41 | 90,92 | 91,82 | -0,48% | 2,69% | 395.000 |
| 29/11/2019 | 93,22 | 93,69 | 92,19 | 92,26 | -1,72% | 1,61% | 188.300 |
| 27/11/2019 | 93,98 | 94,08 | 92,75 | 93,87 | +0,35% | 1,42% | 251.500 |
| 26/11/2019 | 95,63 | 95,90 | 93,20 | 93,54 | -1,89% | 2,82% | 236.000 |
| 25/11/2019 | 93,45 | 95,47 | 93,15 | 95,34 | +2,51% | 2,48% | 426.400 |
| 22/11/2019 | 93,81 | 94,47 | 92,55 | 93,01 | -0,42% | 2,05% | 323.400 |
| 21/11/2019 | 95,04 | 95,04 | 92,57 | 93,40 | -1,51% | 2,60% | 348.000 |
| 20/11/2019 | 92,25 | 95,88 | 92,25 | 94,83 | +2,50% | 3,93% | 640.600 |
| 19/11/2019 | 91,26 | 94,61 | 91,26 | 92,52 | +2,05% | 3,67% | 353.000 |
| 18/11/2019 | 90,23 | 92,19 | 89,89 | 90,66 | +0,25% | 2,55% | 551.000 |
| 15/11/2019 | 90,02 | 91,11 | 89,64 | 90,43 | +1,01% | 1,63% | 351.700 |
| 14/11/2019 | 88,36 | 90,13 | 87,49 | 89,53 | +1,18% | 2,99% | 324.500 |
| 13/11/2019 | 88,97 | 89,09 | 87,83 | 88,49 | -1,21% | 1,42% | 386.300 |
| 12/11/2019 | 90,71 | 91,15 | 89,05 | 89,57 | -1,53% | 2,32% | 272.900 |
| 11/11/2019 | 90,99 | 91,35 | 90,52 | 90,96 | -0,71% | 0,91% | 260.300 |
| 08/11/2019 | 90,29 | 92,24 | 90,00 | 91,61 | +1,08% | 2,48% | 269.700 |
| 07/11/2019 | 90,82 | 91,77 | 90,27 | 90,63 | +0,39% | 1,65% | 269.000 |
| 06/11/2019 | 91,51 | 91,72 | 90,07 | 90,28 | -1,41% | 1,80% | 414.100 |
| 05/11/2019 | 90,02 | 92,18 | 89,76 | 91,57 | +1,59% | 2,69% | 476.100 |
| 04/11/2019 | 90,32 | 90,98 | 88,89 | 90,14 | +0,20% | 2,31% | 410.600 |
| 01/11/2019 | 89,77 | 92,08 | 88,63 | 89,96 | +0,13% | 3,84% | 569.200 |
| 31/10/2019 | 91,07 | 92,33 | 89,42 | 89,84 | -1,26% | 3,20% | 748.000 |
| 30/10/2019 | 92,00 | 95,76 | 89,44 | 90,99 | +4,60% | 6,87% | 1.770.000 |
| 29/10/2019 | 86,77 | 87,27 | 85,57 | 86,99 | +0,55% | 1,96% | 472.500 |
| 28/10/2019 | 84,39 | 87,35 | 84,39 | 86,51 | +2,90% | 3,51% | 438.600 |
| 25/10/2019 | 82,99 | 84,62 | 82,75 | 84,07 | +0,92% | 2,25% | 335.200 |
| 24/10/2019 | 84,47 | 84,73 | 81,86 | 83,30 | -1,05% | 3,40% | 229.800 |
| 23/10/2019 | 84,25 | 85,00 | 83,92 | 84,18 | -0,09% | 1,28% | 267.400 |
| 22/10/2019 | 84,42 | 85,16 | 83,27 | 84,26 | +0,27% | 2,24% | 268.000 |
| 21/10/2019 | 83,23 | 84,59 | 82,53 | 84,03 | +2,30% | 2,48% | 308.400 |